BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38705987)

  • 1. Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis.
    Deng Z; Li B; Yang M; Lu L; Shi X; Lovell JF; Zeng X; Hu W; Jin H
    J Nanobiotechnology; 2024 May; 22(1):225. PubMed ID: 38705987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells.
    Chen M; Zhou B; Zhong P; Rajamanickam V; Dai X; Karvannan K; Zhou H; Zhang X; Liang G
    Prostate; 2017 Apr; 77(5):489-504. PubMed ID: 27990666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bimetallic Polymerization Network for Effective Increase in Labile Iron Pool and Robust Activation of cGAS/STING Induces Ferroptosis-Based Tumor Immunotherapy.
    Wang Z; Zhou P; Li Y; Zhang D; Chu F; Yuan F; Pan B; Gao F
    Small; 2024 May; 20(20):e2308397. PubMed ID: 38072786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy.
    Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G
    Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment.
    Hsieh CH; Hsieh HC; Shih FS; Wang PW; Yang LX; Shieh DB; Wang YC
    Theranostics; 2021; 11(14):7072-7091. PubMed ID: 34093872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
    Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
    Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 10. CD36-mediated ferroptosis dampens intratumoral CD8
    Ma X; Xiao L; Liu L; Ye L; Su P; Bi E; Wang Q; Yang M; Qian J; Yi Q
    Cell Metab; 2021 May; 33(5):1001-1012.e5. PubMed ID: 33691090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis.
    Wang D; Qiu G; Zhu X; Wang Q; Zhu C; Fang C; Liu J; Zhang K; Liu Y
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37192783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 13. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
    Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF
    Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer.
    Ding Q; Tang W; Li X; Ding Y; Chen X; Cao W; Wang X; Mo W; Su Z; Zhang Q; Guo H
    J Control Release; 2023 Nov; 363():221-234. PubMed ID: 37717657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
    Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
    Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy.
    Wang J; Wang Z; Li L; Wang M; Chang J; Gao M; Wang D; Li C
    Acta Biomater; 2024 Jun; 181():362-374. PubMed ID: 38663684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
    Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
    Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
    Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
    Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
    Yu Z; Wang C; Ye Y; Wang S; Jiang K
    J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.